Previous Page  18 / 827 Next Page
Information
Show Menu
Previous Page 18 / 827 Next Page
Page Background

18

International Congress of Immunology 2016

Abstract Book

barrier to the development of specific mechanistic models.

Both extracellular and intracellular structural transitions have

been implicated in TCR “triggering,” but little is known about

whether specific structures within the transmembrane (TM)

regions of the receptor complex are required to support the

coupling of these events through the lipid bilayer. We have

recently shown that the TCRαβ TM domains form a closely

associated coiled-coil interface that provides a structured core

for the TCRαβ-CD3δε-CD3γε-ζζ complex in the membrane. This

interface is mediated by a network of inter-helical hydrogen

bonds between TM sequences that are absolutely conserved

across vertebrate evolution and in both αβ and γδ forms of the

TCR. Receptors with mutations at the key polar residues were

expressed normally but exhibited a severe defect in antigen-

triggered IL-2 production. These data support a model in which

extracellular alterations propagate through the structured TCR/

CD3 TM domains to initiate intracellular signalling and provide a

structural rationale for the ability of T cells to respond to a single

antigenic peptide:MHC ligand through a receptor-intrinsic

conformational mechanism.

2782

Quantitative analysis of Vav1 signalosome in primary CD4 T

cells identify several newVav1 partners including CD226

Gaud, G.

1

, Roncagalli, R.

2

, Gonzalez De Pedro, A.

3

, Malissen, B.

2

,

SAOUDI, A.

1

1

INSERM U 1043, CNRS UMR 5282, Toulouse, France,

2

CIML,

Marseille, France,

3

IPBS, Toulouse, France

A tightly controlled balance of immune cell signaling is

necessary for proper immunity. A dysfunction of this balance

has been observed in several immune mediated diseases. Vav1

is a signaling molecule involved in T cell development and

functions. Recently, our team showed that Vav1 is involved

in several auto-immune diseases such has multiple sclerosis

and myasthenia gravis. However, the molecular mechanisms

by which Vav1 controls these phenotypes are still poorly

understood.

In the present study, we analyzed the composition and dynamic

of Vav1 signalosome in primary CD4

T cells by generating a novel animal model where Vav1 was

tagged at its C-terminus withOneStrepTag (Vav1OST). Following

in vitro

stimulation of primary CD4T lymphocytes, Vav1 was pull-

down at different time-points, and its interactome was analyzed

by mass spectrometry, allowing the characterization of Vav1

interactors and their binding kinetics following stimulation. This

approached allow us to describe the first spatial and temporal

vav1 interactome and to identify numerous new Vav1 partners.

We analyzed the major biological processes of these interactors

and as expected most of them are involved in TCR signaling.

This proteomic study also leads us to identify 4 co-receptors

involved in immunological synapse formation. Among them,

CD226 is involved in CD4 T cell proliferation and differentiation.

We demonstrate here for the first time that Vav1 is a crucial

effector of CD226 signaling in CD4T cells.

3964

Engagement of TCR with foreign and self antigens trigger

distinct signaling pathways to generate different T cell

responses

Shiokawa, M.

1

, Ishikawa, E.

1

, Ogata, M.

2

, Saito, T.

3

, Yamasaki, S.

1

1

Division of Molecular Immunology, Medical Institute of

Bioregulation, Kyushu University, Fukuoka, Japan,

2

Department of

Biochemistry and Proteomics, Mie University Graduate School of

Medicine, Tsu, Japan,

3

Laboratory for Cell Signaling, RIKEN Center

for IMS, Yokohama, Japan

Mature T cells are activated by recognizing foreign antigens

(Ags) through T cell receptor (TCR). Although it was widely

believed that endogenous self Ags do not activate mature T

cells, recent studies have demonstrated that they can induce T

cell maintenance in the periphery. However, it remains unclear

how these distinct responses are generated through the same

receptor. To address this issue, we compared the contribution

of Erk, a pivotal MAP kinase for cell growth and survival, to

these distinct responses. By establishing mature T cell-specific

Erk1/2-deficient mice, we found that mature T cells could

survive in the periphery without Erk. Moreover, homeostatic T

cell proliferation was observed in the absence of Erk, suggesting

that Erk is not essential for T cell maintenance induced by self

Ags. In contrast, OVA-specific responses, such as proliferation

or cytokines production, were abrogated by loss of Erk. Thus,

T cell responses induced by self/foreign Ags are regulated

differentially, at least concerning the requirement of Erk. Next, to

examine the correlation of peptide affinity and Erk dependency,

OT-I TCR Tg T cells transferred into TAP-deficient mice were

stimulated with peptides with different affinities and examined

T cell responses. High-affinity peptide SIINFEKL could induce

vigorous proliferation

in vivo

, whereas low-affinity peptides

induced survival without proliferation. Again, we found that

the former response was largely dependent on Erk. Collectively,

these results suggest that the strength of TCR signal may be

determine different mature T cell responses through distinct

signaling pathways.

Autoimmunity 1

2907

Rogue germinal center B cells: unconventional lymphocytes

released by FAS inactivation that drive IgE and

autoantibody production

Butt, D.

1

, Chan, T.

1

, Bourne, K.

1

, Hermes, J.

1

, Strasser, A.

2

, Tangye, S.

1

,

Phan, T.

1

, Rao, V.K.

3

, Brink, R.

1

1

Garvan Institute of Medical Research, Sydney, Australia,

2

The

Walter and Eliza Hall Institute of Medical Research, Melbourne,

Australia,

3

National Institute of Allergy and Infectious Diseases,

NIH, Bethesda, United States

The mechanistic links between genetic variation and

autoantibody production in autoimmune disease remain

obscure. Inactivating mutations in the death receptor FAS

or its ligand (FASL) cause Autoimmune Lymphoproliferative

Syndrome (ALPS) and lupus-like autoimmune diseases. FAS

is thought to safeguard against autoantibody production by